埃立克体病
血栓性微血管病
强力霉素
医学
肾移植
移植
病理
免疫学
内科学
病毒学
疾病
生物
微生物学
抗生素
滴答声
作者
Waleed Hassan,Manish Talwar,Vasanthi Balaraman,Miklos Z. Molnar
摘要
Abstract Fever of unknown origin and the clinical picture of thrombotic microangiopathy (TMA) are diagnostic challenges in the early period after kidney transplantation. Here, we report a case of human monocytic ehrlichiosis in a renal allograft recipient who presented with fever and clinical picture of TMA in the first month post–kidney transplant. Despite broad coverage with multiple antimicrobial agents, fever and hematological abnormalities persisted for several days. A history of contact exposure and living in an endemic area raised clinical suspicion for human monocytic ehrlichiosis (HME), and empiric treatment with doxycycline was initiated. Definitive diagnosis of HME was confirmed by polymerase chain reaction (PCR) for Ehrlichia chaffeensis . Human ehrlichiosis should be considered within the differential diagnosis in kidney transplant recipients with the clinical picture of TMA and fever of unknown origin. Furthermore, early treatment with doxycycline enhances rapid resolution of clinical and laboratory recovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI